What is Flyte?
Flyte by Pelvital USA offers innovative pelvic floor therapy solutions designed to promote cellular healing and improve bladder control. Their flagship product, Flyte, is an FDA-cleared intravaginal device that utilizes mechanotherapy to treat stress urinary incontinence effectively and conveniently at home. The company targets women experiencing bladder leaks and incontinence, providing a non-surgical alternative backed by clinical research and expert recommendations. Flyte also includes a supportive app and access to pelvic health experts to enhance the user experience and treatment outcomes.
How much funding has Flyte raised?
Flyte has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2024): $5M with participation from Boomerang Ventures, Wisconsin Investment Partners, Life Science Angels, VisionTech Partners, Pier 70 Ventures, and Blue Pacific Fund
Key Investors in Flyte
Boomerang Ventures
Boomerang Ventures is a venture studio and fund that focuses on connected health technologies, aiming to innovate healthcare through tech-enabled medical devices and improved care models. They actively seek early-growth stage companies to transform the healthcare ecosystem.
Wisconsin Investment Partners
Wisconsin Investment Partners is a prominent angel investment group and business incubator based in Wisconsin, providing funding and support to entrepreneurs and fostering innovation within the entrepreneurial ecosystem.
Life Science Angels
Life Science Angels is a leading angel investment group focused on early-stage life science companies, providing investment opportunities and support to entrepreneurs in the life sciences sector.
What's next for Flyte?
With this substantial enterprise-level funding, Flyte is poised to accelerate its market penetration and further develop its innovative pelvic floor therapy solutions. The strategic investment signals a strong belief in the company's potential to disrupt the women's health market by offering effective, at-home treatment options for stress urinary incontinence. Future endeavors will likely focus on expanding product offerings, enhancing the user experience through its supportive app, and broadening access to pelvic health expertise, solidifying its position as a leader in the field.
See full Flyte company page
